Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dysgeusia/horúčka

Odkaz sa uloží do schránky
Strana 1 od 29 výsledky

The Clinical Spectrum of Zika Virus in Returning Travelers.

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The clinical spectrum of Zika virus had, to date, been described in small series from endemic/epidemic countries and is not well established. We describe the clinical manifestations of laboratory-proven Zika virus infection in Israeli travelers during December 2015-February 2016, and review all

Clinical Characteristics of COVID-19 Patients With Gastrointestinal Symptoms in Northern Italy: A Single-Center Cohort Study

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Introduction: The most typical presentation of COVID-19 is an acute respiratory syndrome whose most common symptoms include fever, cough, and dyspnea. However, gastrointestinal symptoms, such as diarrhea and nausea/vomiting, are

How to optimize HCV therapy in genotype 1 patients: management of side-effects.

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Antiviral therapy for chronic hepatitis C has dramatically changed with the advent of triple therapy incorporating direct-acting antivirals (DAAs) such as the protease inhibitors (PI) boceprevir and telaprevir. Such triple-therapy is associated with a new spectrum of side-effects which can hamper
BACKGROUND Rates of sustained virological response (SVR) to peginterferon-ribavirin are low in patients with hepatitis C virus (HCV) genotype 1 and HIV. We aimed to assess efficacy and safety of triple therapy with boceprevir plus pegylated interferon alfa-2b (peginterferon) and ribavirin, which
OBJECTIVE The primary objective of this study was to evaluate the safety and tolerability of a formulated IL-12 plasmid administered intraperitoneally (IP) in conjunction with intravenous (IV) carboplatin/docetaxel in platinum-sensitive ovarian cancer patients. METHODS Escalating doses of IL-12
OBJECTIVE The treatment of choice for superficial bladder TCC is endoscopic resection, followed or not by intravesical immuno/chemotherapy. Some patients are not responders to common intravesical therapy and are more exposed to disease progression. In this case the suitable treatment is radical

Correlations of Online Search Engine Trends with Coronavirus disease (COVID-19) Incidence: Infodemiology Study.

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Coronavirus disease (COVID-19) is the latest pandemic of the digital age. With the Internet harvesting large amounts of data from the general population in real-time, public databases such as Google Trends (GT) and the Baidu Index (BI) can be an expedient tool to assist public health

Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Objective: The aim of this manuscript is to investigate transversally Ear Nose Throat (ENT) symptoms COVID-19 infection correlated and to study the neurotropism and neuroinvasiveness of the virus in the head-neck district through the
OBJECTIVE To determine the ability of amifostine to reduce the severity and/or incidence of the acute toxicities of concurrent chemotherapy and radiotherapy (RT) for non-small-cell lung cancer. METHODS Patients with inoperable, nonmetastatic non-small-cell lung cancer receiving concurrent

Comment on "Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S.

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than 1,000,000 persons worldwide, of whom over 50,000 have died (1). Having been infected by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2),

The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers.

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
OBJECTIVE ABT-288 is a potent and selective H3 receptor antagonist with procognitive effects in several preclinical models. In previous studies, 3 mg once daily was the maximal tolerated dose in healthy volunteers. This study characterized the safety, tolerability and pharmacokinetics of ABT-288 in
Objectives: The primary objectives of the study are: 1. To assess the effect of hydroxychloroquine (HCQ) in reducing SARS-CoV-2 viral shedding by PCR in infected pregnant women with mild symptoms. 2. To assess the efficacy of HCQ to

Relationship between anosmia and hospitalisation in patients with coronavirus disease 2019: an otolaryngological perspective

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Objective: A study was carried out to evaluate the relationship between anosmia and hospital admission in coronavirus disease 2019 patients. Methods: The clinical data of 1534

Acute Corneal Endothelial Graft Rejection with Coinciding COVID-19 Infection

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Purpose: To report a case of acute corneal endothelial graft rejection with concurrent onset of coronavirus disease 2019 (COVID-19) symptoms. Observations: A 31-year-old

Olfactory and Gustatory Dysfunctions as a Clinical Manifestation of Coronavirus Disease 2019 in a Malaysian Tertiary Center

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Objective: To investigate the prevalence of olfactory and gustatory dysfunction among patients with COVID-19 infection and the recovery rate. Methods: Adult patients (≥18
Pripojte sa k našej
facebookovej stránke

Najkompletnejšia databáza liečivých bylín podporovaná vedou

  • Pracuje v 55 jazykoch
  • Bylinné lieky podporené vedou
  • Rozpoznávanie bylín podľa obrázka
  • Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
  • Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
  • Vyhľadajte liečivé byliny podľa ich účinkov
  • Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume

Google Play badgeApp Store badge